Table 2 Clinical data of conservatively treated patients.
| Event‐free survivors | Cardiovascular death/readmission for CHF | p Value | |
|---|---|---|---|
| Number | 48 | 9 | |
| Women | 25 (52%) | 4 (44%) | 0.730 |
| Atrial fibrillation | 4 (8%) | 2 (22%) | 0.237 |
| Coronary artery disease | 14 (30%) | 5 (56%) | 0.143 |
| Moderate aortic stenosis | 38 (79%) | 6 (67%) | 0.412 |
| Severe aortic stenosis | 9 (21%) | 3 (33%) | |
| Age (years) | 69 (13) | 73 (8) | 0.416 |
| Ejection fraction (%) | 60 (4) | 53 (9) | 0.049 |
| LVMI (g/m2) | 116 (37) | 131 (45) | 0.317 |
| Mean pressure gradient (mm Hg) | 31 (22) | 38 (13) | 0.385 |
| Aortic valve area (cm2) | 0.98 (0.33) | 0.87 (0.07) | 0.140 |
| NT‐proBNP at baseline (pg/ml) | 331 (129–881) | 1102 (796–2966) | 0.002 |
Values are expressed as number (%), mean (SD) or median (interquartile range).
CHF, decompensated heart failure; LVMI, left ventricular mass index; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.